← Leaderboards
David I Hirsh
Columbia University Health Sciences
$3,046,428
Attributed
$3,046,428
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,046,428 · 2
By mechanism
C06$2,000,000 · 1
R01$1,046,428 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Gregg G Gundersen$21,629,601
- Richard Bert Vallee$17,107,663
- Liza A Pon$17,963,914
- Fred Chang$14,463,300
- Richard Axel$3,875,356
Others in their field
Top investigators on “Bacterial Antigens”
- Myron Max Levine · University Of Maryland Baltimore$30,341,987
- Samuel M Behar · Brigham And Women'S Hospital$17,368,588
- Roy Curtiss · Washington University$15,928,327
- Richard S Blumberg · Children'S Hospital Boston$15,876,125
- Chyung-Ru Wang · University Of Chicago$15,795,387
- Robert L Modlin · University Of California Los Angeles$14,946,595
Research focus
Bacterial AntigensCell MigrationCytokine ReceptorsGene ExpressionGene MutationGenetically Modified AnimalsGenetic MarkersHelper T LymphocyteInhibitor /AntagonistInterleukin 1Laboratory MouseLipopolysaccharidesListeriaListeria InfectionsLymphocyte ProliferationProtein Structure Function
Grant awards (4)
IN VIVO FUNCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST$355,902
R01 · FY2002 · AI
LABORATORIES FOR RESEARCH IN PARKINSON'S DISEASE$2,000,000
C06 · FY2001 · RR
IN VIVO FUNCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST$348,743
R01 · FY2001 · AI
IN VIVO FUNCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST$341,783
R01 · FY2000 · AI